BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 02/08/2016

FDA Clears Way for Tolvaptan Tablets Approval

The US Food and Drug Administration has ruled that the 60mg SAMSCA (tolvaptan) tablets were not withdrawn from sale due to safety or efficacy concerns, paving the way for potential approval of abbreviated new drug applications for the medication.

Source: Federal Register — Food and Drug AdministrationOpen original release →